Extended Broad-Spectrum -Lactamases Conferring Transferable Resistance to Newer -Lactam Agents in Enterobacteriaceae: Hospital Prevalence and Susceptibility Patterns
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Before 1985 at the Pitié-Salpêtrière Hospital in Paris (2,400 beds), resistance to cefotaxime in clinical isolates of Enterobacteriaceae involved only species producing inducible class 1 beta-lactamase. Between November 1985 and April 1987, however, 62 isolates (57 of Klebsiella pneumoniae and five of Escherichia coli) showed decreased susceptibility to cefotaxime (mean MIC, 8-16 micrograms/mL). The transferability of cefotaxime resistance in E. coli K12 was demonstrated for 15 of 16 selected isolates. By isoelectric focusing using iodometric detection with 20 mg of ceftriaxone/100 mL and determination of substrate and inhibition profiles, three beta-lactamases mediating cefotaxime resistance were identified as SHV-2 (isoelectric point [pI] 7.6), CTX-1 (pI 6.3), and "SHV-2-type" or SHV-3 (pI 6.98). The three beta-lactamases hydrolyzed penicillins and cephalosporins (including cefotaxime and ceftriaxone) and were therefore designated "extended broad-spectrum beta-lactamases" (EBS-Bla). The enzymes conferred to derivatives a high level of resistance to amoxicillin, ticarcillin, piperacillin, and cephalothin and a decreased degree of susceptibility (i.e., MICs increased by 10- to 800-fold) to cefotaxime, ceftriaxone, ceftazidime, and aztreonam. These beta-lactamases did not affect the activity of cephamycins (cefoxitin, cefotetan, moxalactam) or imipenem. Synergy between clavulanate or sulbactam (2 micrograms/mL) and amoxicillin was greater against derivatives producing EBS-Bla than against those producing TEM-1, TEM-2, or SHV-1; this synergy was greater with clavulanate than with sulbactam against derivatives producing SHV-2 and the SHV-2-type enzyme but was similar with clavulanate and sulbactam against those producing CTX-1. A double-disk synergy test performed with cefotaxime and Augmentin disks (placed 30 mm apart, center to center) seemed a useful and specific test for the detection of strains producing EBS-Bla.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotic sensitivity testing. Report of an international collaborative study.
Ericsson, H., & Sherris, J. C. (1971) · PubMed · Cited by 1,324
Knothe, H., Shah, P., Krcmery, V., Antal, M., & Mitsuhashi, S. (1983) · Infection · doi:10.1007/bf01641355 · Cited by 912
Evolution of plasmid-coded resistance to broad-spectrum cephalosporins
Kliebe, C., Nies, B. A., Meyer, J. F., Tolxdorff-Neutzling, R. M., & Wiedemann, B. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.28.2.302 · Cited by 415
Sirot, D., Sirot, J., Labia, R., Morand, A., Courvalin, P., Darfeuille-Michaud, A., Perroux, R., & Cluzel, R. (1987) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/20.3.323 · Cited by 358
Microbial Resistance to Newer Generation f3-lactam Antibiotics: Clinical and Laboratory Implications
Sanders, C. C., & Sanders, W. E. (1985) · Journal of Infectious Diseases · doi:10.1093/infdis/151.3.399 · Cited by 210
Emergence of Resistance to Cefamandole: Possible Role of Cefoxitin-Inducible Beta-Lactamases
Sanders, C. C., & Sanders, W. E. (1979) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.15.6.792 · Cited by 179
Novel R-factor borne β-lactamase of Escherichia coli confering resistance to cephalosporins
Bauernfeind, A., & Hörl, G. (1987) · Infection · doi:10.1007/bf01644127 · Cited by 105
Gootz, T. D., Sanders, C. C., & Goering, R. V. (1982) · The Journal of Infectious Diseases · doi:10.1093/infdis/146.1.34 · Cited by 93
Cited by
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,491
Podschun, R., & Ullmann, U. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.4.589 · Cited by 2,688
Bradford, P. A. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.933-951.2001 · Cited by 2,618
A functional classification scheme for beta-lactamases and its correlation with molecular structure
Bush, K., Jacoby, G. A., & Medeiros, A. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1211 · Cited by 2,475
Gold, H. S., & Moellering, R. C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611073351907 · Cited by 1,070
Extended-spectrum beta-lactamases
Philippon, A., Labia, R., & Jacoby, G. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.8.1131 · Cited by 767
Self-citationGoldmann, D. A. (1996) · JAMA · doi:10.1001/jama.1996.03530270074035 · Cited by 753
EUCAST expert rules in antimicrobial susceptibility testing
Leclercq, R., Cantón, R., Brown, D. F. J., Giske, C. G., Heisig, P., MacGowan, A. P., Mouton, J. W., Nordmann, P., Rodloff, A. C., Rossolini, G. M., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03703.x · Cited by 683
Extended-spectrum ß-lactamases in gram negative bacteria
Rawat, D., & Nair, D. (2010) · Journal of Global Infectious Diseases · doi:10.4103/0974-777x.68531 · Cited by 588
Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens
Pfeifer, Y., Cullik, A., & Witte, W. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2010.04.005 · Cited by 494
Wiener, J. (1999) · JAMA · doi:10.1001/jama.281.6.517 · Cited by 485
Osano, E., Arakawa, Y., Wacharotayankun, R., Ohta, M., Horii, T., Ito, H., Yoshimura, F., & Kato, N. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.1.71 · Cited by 440
Rupp, M. E., & Fey, P. D. (2003) · Drugs · doi:10.2165/00003495-200363040-00002 · Cited by 379
Tängdén, T., Cars, O., Melhus, A., & Löwdin, E. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00220-10 · Cited by 372
Colodner, R., Rock, W., Chazan, B., Keller, N., Guy, N., Sakran, W., & Raz, R. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-003-1084-2 · Cited by 364
Kim, Y.-K., Pai, H., Lee, H.-J., Park, S.-E., Choi, E.-H., Kim, J., Kim, J.-H., & Kim, E.-C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1481-1491.2002 · Cited by 357
Saladin, M., Cao, V. T. B., Lambert, T., Donay, J.-L., Herrmann, J.-L., Ould-Hocine, Z., Verdet, C., Delisle, F., Philippon, A., & Arlet, G. (2002) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2002.tb11126.x · Cited by 348
Self-citationAntibiotic selective pressure and development of bacterial resistance
Kolář, M., Urbánek, K., & Látal, T. (2001) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(01)00317-x · Cited by 335
Valverde, A., Coque, T. M., Sánchez-Moreno, M. P., Rollán, A., Baquero, F., & Cantón, R. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.10.4769-4775.2004 · Cited by 333
Peña, C., Pujol, M., Ardanuy, C., Ricart, A., Pallares, R., Liñares, J., Ariza, J., & Gudiol, F. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.1.53 · Cited by 311
Detection of β-lactamase-mediated resistance
Livermore, D. M., & Brown, D. F. J. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.suppl_1.59 · Cited by 307
Characterization of beta-lactamases
Bush, K. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.3.259 · Cited by 305
Emergence of Imipenem-Resistant Gram-Negative Bacilli in Intestinal Flora of Intensive Care Patients
Armand-Lefèvre, L., Angebault, C., Barbier, F., Hamelet, E., Defrance, G., Ruppé, E., Bronchard, R., Lepeule, R., Lucet, J.-C., El Mniai, A., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01823-12 · Cited by 300
Eckert, C., Gautier, V., Saladin-Allard, M., Hidri, N., Verdet, C., Ould-Hocine, Z., Barnaud, G., Delisle, F., Rossier, A., Lambert, T., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1249-1255.2004 · Cited by 278
Self-citationCTX-M: changing the face of ESBLs in the UK
Livermore, D. M., & Hawkey, P. M. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki239 · Cited by 278
Expression of resistance to tetracyclines in strains of methicillin-resistant Staphylococcus aureus
Trzcinski, K., Cooper, B. S., Hryniewicz, W., & Dowson, C. G. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.6.763 · Cited by 275
Spread of OXA-48-Encoding Plasmid in Turkey and Beyond
Carrër, A., Poirel, L., Yilmaz, M., Akan, O. A., Feriha, C., Cuzon, G., Matar, G., Honderlick, P., & Nordmann, P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01312-09 · Cited by 273
Ito, H., Arakawa, Y., Ohsuka, S., Wacharotayankun, R., Kato, N., & Ohta, M. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.4.824 · Cited by 266
Hasdemir, U. O., Chevalier, J., Nordmann, P., & Pagès, J.-M. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.6.2701-2706.2004 · Cited by 131
Trends in β‐Lactam Resistance Among Enterobacteriaceae
Nordmann, P. (1998) · Clinical Infectious Diseases · doi:10.1086/514905 · Cited by 124
Pallecchi, L., Malossi, M., Mantella, A., Gotuzzo, E., Trigoso, C., Bartoloni, A., Paradisi, F., Kronvall, G., & Rossolini, G. M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4556-4561.2004 · Cited by 94
Ahmed, S., Ali, M. M. M., Mohamed, Z., Moussa, T. A., & Klena, J. D. (2014) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-13-22 · Cited by 64
Chandel, D. S., Johnson, J. A., Chaudhry, R., Sharma, N., Shinkre, N., Parida, S., Misra, P. R., & Panigrahi, P. (2011) · Journal of Medical Microbiology · doi:10.1099/jmm.0.027375-0 · Cited by 57
Montealegre, M. C., Roy, S., Böni, F., Hossain, M. I., Navab-Daneshmand, T., Caduff, L., Faruque, A. S. G., Islam, M. A., & Julian, T. R. (2018) · Applied and Environmental Microbiology · doi:10.1128/aem.01978-18 · Cited by 55
Kamathewatta, K., Bushell, R., Rafa, F., Browning, G., Billman-Jacobe, H., & Marenda, M. (2020) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-020-00828-0 · Cited by 27
Metadata
- Authors
- Jarlier, V., Nicolas, M.-H., Fournier, G., & Philippon, A.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1988-07-01
- Volume
- 10
- Issue
- 4
- Pages
- 867-878
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W1989925309
- Cited by
- 1,559
- References
- 8
- FWCI
- 10.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.